MELLIN MARK 4
4 · ILEX ONCOLOGY INC · Filed Nov 13, 2003
Insider Transaction Report
Form 4
MELLIN MARK
Senior Vice President & CFO
Transactions
- Exercise/Conversion
Common Stock
2003-11-12$5.78/sh+3,000$17,340→ 3,000 total
Footnotes (1)
- [F1]On 9/3/03, 18,750 shares vested. The remaining options vest in increments of 18,750 shares on 9/3/04, 9/3/05, and 9/3/06.